Personetics Launches Sustainability Insights, a Next-Generation Solution for Banks to Help Customers Reduce Their Carbon Footprint
Personetics, the leading global provider of financial data-driven personalization, customer engagement, and advanced money management capabilities for financial institutions, today announces the launch of Sustainability Insights. This new offering, included within the Personetics engagement platform, will help banks meet growing customer demand and regulatory expectations for environmentally responsible banking and sustainable finance. Personetics is partnering with industry-leading impact fintech ecolytiq, whose Sustainability-as-a-Service® solution enhances the data models of Sustainability Insights, making them more precise, personalized, and actionable.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220426005128/en/
Examples of Personetics’ sustainability capabilities (Graphic: Business Wire)
The Personetics Sustainability Insights solution is the world’s first to show banking customers the carbon footprint of every banking transaction and recommend personalized actions to reduce carbon emissions – such as by making purchases from lower-carbon merchants or categories or saving for climate-friendly financial goals. Sustainability Insights are fully embedded into the Personetics financial data-driven engagement platform, based on advanced data analytics of billions of customer transactions.
Beyond just tracking carbon emissions and showing customers their personal carbon footprint, Sustainability Insights is a complete integrated approach that also assesses other factors, such as overall ESG company information to further calculate the individual impact. It also enables banks to recommend their own existing products which may help a customer take more sustainable financial decisions.
Sustainability Insights is based on Personetics’ four pillars of sustainable finance strategy:
- Integrated: The Sustainability Insights are fully integrated into the existing financial data-driven engagement platform and accessible within each participating financial institution’s digital channels; customers can now see their carbon footprint and receive recommendations within their bank’s mobile app.
- Relatable: Sustainability Insights are based on each customer’s own financial transaction data. People can see the carbon emissions of their everyday spending decisions – and get advice on how to reduce carbon emissions with their financial choices.
- Interactive: Sustainability Insights are easy to understand and engaging for banking customers, with an easy-to-use digital banking user experience.
- Actionable: Customers can quickly take action to reduce their carbon emissions, such as by opening a savings account to save money for solar panels or an electric vehicle or deciding to purchase a different product or shop at a more climate-friendly store.
Key capabilities of the Sustainability Insights offering include:
- Providing a personalized, holistic financial map that visually demonstrates the carbon emissions of customer spending or investments.
- Giving customers the ability to take action to reduce their carbon emissions with personalized insights and advice, depending on their financial situation. For example, the solution might suggest alternative merchants that are more carbon friendly, suggest a savings goal for installing solar panels, offer green investment products, or allow a customer to set a carbon target and track their progress through their spending.
- Personalization and Engagement: Actively engaging with the user to increase the accuracy of the insights via quizzes and feedback insights.
To provide banking customers with the most precise, and actionable climate impact data, Personetics has integrated ecolytiq's country level models with its own proprietary capabilities. ecolytiq provides financial institutions with country-specific data sources and models to help them achieve best-in-class carbon impact calculations.
For increased depth of data, Personetics’ Sustainability Insights also partners with additional global providers of carbon emission research to offer various merchants footprint or spending categories within specific countries.
Personetics’ Sustainability Insights will empower financial institutions to be leaders in environmentally responsible banking and will help customers take action to choose a more sustainable lifestyle with better-informed financial choices. Data from Deloitte shows 28% of consumers have already stopped purchasing certain brands or products due to sustainable or ethical concerns, and dozens of the world’s banks are already committing to change through the UN’s Principles for Responsible Banking.
Banks will also be able to feed insights from the Personetics platform into their ESG reporting by tracking and measuring the actions customers are taking to reduce their carbon footprint. This can help financial institutions demonstrate significant leadership in supporting their customers while fighting climate change.
David Sosna, CEO of Personetics, said:
“We are excited to launch our new Sustainability Insights, backed by the industry-leading data sources of our partner ecolytiq. Personetics Sustainability Insights are the next evolution of sustainable finance – beyond just showing bank customers their carbon footprint, we offer them specific actions that they can take today to reduce their carbon impact, choose climate-friendly savings goals, and push the industry in a greener direction.
“Sustainability Insights also drive business impact for financial institutions by improving customer engagement, creating new occasions for targeted cross-selling, and recommending specific banking products and new accounts in a way that is personalized for each customer’s financial situation and future goals. This will create deeper relationships with banking customers and ultimately support banks’ ESG reporting. Every financial institution can be a leader in green banking with Sustainability Insights.”
Ulrich Pietsch, CEO, ecolytiq said:
“The financial industry will play a major role in fighting climate change. This starts by providing people with the information they need to make greener decisions. Banks that act now by embracing sustainability will be the first to reap its benefits for years to come. By partnering with Personetics, we’re excited to be able to help even more financial institutions across the world with in-depth data about their customers’ carbon footprint, so they can suggest actions to improve it.”
The new Sustainability Insights offering is now available on the Personetics platform and is ready to be activated by Personetics’ existing global network of 80 financial institutions with a combined reach of 120 million bank customers.
About Personetics:
Personetics is the global leader in financial data-driven personalization, customer engagement, and advanced money management capabilities for financial services. We are creating the future of “Self-Driving Finance,” where banks can proactively act on their customers’ behalf to help improve their financial wellness and achieve financial goals.
Our industry-leading data analytics solutions harness customer financial transaction data to provide day-to-day actionable insights, personalized recommendations, product-based financial advice, and automated financial wellness programs. We offer solutions for mass market consumer banking, SMB banking, wealth management, and credit card issuers.
We drive business impact for financial institutions by improving relevant product targeting for accurate, efficient cross-selling and upselling. We help financial institutions deepen their customer relationships, increase core deposits and customer retention, expand share of wallet, and boost Customer Lifetime Value.
Personetics currently serves over 80 financial institutions spanning 30 global markets, reaching 120 million customers. We are backed by leading venture capital and private equity investors, with offices in New York, London, Tel Aviv, Singapore, Rio de Janeiro, Tokyo, Paris, Madrid, and Sydney. Learn more at personetics.com
About ecolytiq:
The Sustainability-as-a-Service ® solution from ecolytiq enables banks, fintech companies and financial service providers to show their customers the individual impact their purchasing behavior is having on the environment in real time. The ecolytiq software calculates personal environmental impacts, such as CO2 values, on the basis of payment transactions and educates consumers on sustainable spending habits through climate insights. Learn more at www.ecolytiq.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220426005128/en/
Contact information
Media inquiries
Toby Earnshaw / Aimee Cashmore
personetics@pancomm.com
Michal Milgalter, Head of Global Marketing
Michal.milgalter@personetics.com
Media contact ecolytiq:
Yuki Hayashi I ecolytiq GmbH I media@ecolytiq.com
phone: +49 30 2201232-80
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Phase 1 Results for its TGFβR2×PD-1 Bispecific Antibody in Advanced Colorectal Cancer and KRAS G12D Inhibitor in Advanced Pancreatic Ductal Adenocarcinoma19.10.2025 20:30:00 EEST | Press release
Incyte (Nasdaq:INCY) announced the first clinical data evaluating its TGFβR2×PD-1 bispecific antibody (INCA33890) for patients with microsatellite stable (MSS) colorectal cancer; and its potent, selective and orally bioavailable KRAS G12D inhibitor (INCB161734) for patients with KRAS G12D mutations, specifically pancreatic ductal adenocarcinoma (PDAC). The data were featured in two oral sessions (Investigational immunotherapy; Abstract #1522MO and Developmental therapeutics; Abstract #916O, respectively) at the European Society of Medical Oncology (ESMO) Congress 2025. “The proof-of-concept data highlight the potential of INCA33890 and INCB161734 to address significant medical needs in patients with advanced solid tumors, including MSS colorectal cancer and PDAC,” said Pablo J. Cagnoni, M.D., President and Head of Research and Development, Incyte. “These results, including the favorable safety profiles as monotherapies, support continued clinical development. We look forward to explori
Corcept Presents ESMO 2025 Late-Breaker: Relacorilant Demonstrates Benefit in Patients with Platinum-Resistant Ovarian Cancer with Prior PARP Inhibitor Treatment19.10.2025 12:15:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today shared new late-breaking data from its pivotal Phase 3 ROSELLA trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer at the European Society for Medical Oncology (ESMO) 2025 Annual Meeting. The data demonstrated a progression-free survival (PFS) benefit for patients who experienced disease progression while on or after taking a PARP inhibitor (PARPi), a patient population with particularly poor prognosis. The presentation slides can be found here. The company also announced expansion of the Phase 2 BELLA trial in a poster session at ESMO, found here. New relacorilant data presented at ESMO demonstrated a consistent benefit in PARPi subgroups to overcome chemotherapy resistance. Relaco
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA ™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 202518.10.2025 14:00:00 EEST | Press release
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases where surgical removal of the tumor is not an option will be presented as a poster during the 2025 European Society for Medical Oncology Congress (ESMO), taking place October 17-21 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251018921529/en/ “These long-term Phase 3 MOTION results add to the established body of evidence supporting vimseltinib as a best-in-class treatment for TGCT,” said Matthew L. Sherman, M.D., Chief Medical Officer of Deciphera. “TGCT often causes debilitating pain, stiffness and impaired mobility and these results demonstrate the durable benefit that vimseltinib can offer patients.” Summary of Data and Findings from the 2-year results of the MOTION Phase
ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 17:09:00 EEST | Press release
ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 17:00:00 EEST | Press release
Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the study increased considerably to 76.2% (95% CI: 63.8, 86.0) by blinded independent review committee (BICR) per RECIST v1.1, from 54% at Week 25. The study also showed continued clinically meaningful improvements in key secondary endpoints related to patient outcomes such as pain and function. The safety profile was consistent with previously reported data. The results are being presented today in the Sarcoma mini-oral session at the European Society for Medical
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom